Table 3.

Treatment and response data compared between White and non-White EoE patients

	White (n = 426)	Non-White (n = 49)	p
Type of steroid used (n, %)			0.06
Fluticasone	140 (33)	8 (16)
Budesonide	285 (67)	41 (84)
Mean steroid dose (mcg ± SD)	1755 ± 711	1415 ± 635	0.002
Symptom response (n, %)*	130 (78)	9 (64)	0.27
Post-treatment peak eosinophil count (mean eos/hpf ± SD)	22.5 ± 34.3	39.0 ± 49.8	0.003
p value vs baseline	< 0.001	0.02
Histologic response (n, %)
<15 eos/hpf	253 (59)	20 (41)	0.01
≤6 eos/hpf	223 (52)	18 (27)	0.04
<1 eos/hpf	131 (31)	12 (24)	0.37
Post-treatment endoscopic findings (n, %)
Normal	84 (20)	15 (31)	0.08
Exudates	96 (23)	16 (33)	0.11
Rings	206 (49)	7 (15)	< 0.001
Edema	114 (27)	17 (35)	0.24
Furrows	192 (46)	20 (42)	0.58
Stricture	145 (35)	8 (17)	0.01
Narrowing	80 (19)	1 (2)	0.003
Crepe-paper mucosa	3 (1)	1 (2)	0.33
Dilation	139 (33)	8 (19)	0.04
Candida	32 (8)	2 (4)	0.38
Endoscopic response (n, %)	311 (73)	26 (54)	0.006
Post-treatment endoscopic severity (mean scores ± SD)
ERFES**	2.3 ± 1.9	2.2 ± 2.0	0.83
p value vs baseline	< 0.001	0.008
ESS	1.8 ± 1.5	1.4 ± 1.5	0.09
p value vs baseline	< 0.001	0.13

^*available for 168 and 14;

^**available for 238 and 16